Kazia Therapeutics
KZIA
10 hedge funds and large institutions have $4.01M invested in Kazia Therapeutics in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 6 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
20% less capital invested
Capital invested by funds: $5.03M → $4.01M (-$1.02M)
33% less funds holding
Funds holding: 15 → 10 (-5)
83% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 6
95% less call options, than puts
Call options by funds: $4K | Put options by funds: $84K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Envestnet Asset Management
Chicago,
Illinois
|
+$263K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$262K |
| 3 |
Morgan Stanley
New York
|
+$121K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$28.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$26.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$176K |
| 2 |
TW
Transform Wealth
Greenwood Village,
Colorado
|
-$120K |
| 3 |
SG Americas Securities
New York
|
-$56.9K |
| 4 |
TCWM
Total Clarity Wealth Management
St. Charles,
Illinois
|
-$54K |
| 5 |
Renaissance Technologies
New York
|
-$25.4K |
KZIA Hedge Fund Activity: Q4 2021 in Review
10 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Kazia Therapeutics (KZIA) for Q4 2021, worth a combined $4.01M — down 20% from $5.03M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of KZIA and 1 opened new positions — a net loss of 5 holders — while 2 trimmed existing stakes and 5 added.
The largest buyer was Envestnet Asset Management, opening a new position worth an estimated $263K. The largest seller was Citadel Advisors, exiting entirely with an estimated $176K sold.
- 10 institutional investors held Kazia Therapeutics (KZIA) as of Q4 2021, down from 15 in Q3 2021.
- Funds reported $4.01M of Kazia Therapeutics stock for Q4 2021, down 20% quarter-over-quarter.
- 1 fund opened new Kazia Therapeutics positions in Q4 2021 and 6 closed out, a net change of -5 holders.
- The largest Kazia Therapeutics buyer in Q4 2021 was Envestnet Asset Management, an estimated $263K added.
- The largest Kazia Therapeutics seller in Q4 2021 was Citadel Advisors, an estimated $176K sold.
Based on aggregated 13F filings for Q4 2021.